Emergency Room Visits and Older Patients (ER2)
ER2
1 other identifier
observational
356
1 country
1
Brief Summary
Today's population is living longer than prior generations. Senior patients, defined as 65 years or older, are therefore increasing in number, and representing a larger number of hospitalized patients. Thus, assessing and addressing the needs of the growing number of older ER users is essential. The overall objective of the study is to examine the feasibility and the epidemiology of two screening tools ("Programme de Recherche sur l'Intégration des Services pour le Maintien de l'Autonomie" (PRISMA-7) and Emergency Room Evaluation and recommendations (ER2)) used in the Emergency Room of Jewish General Hospital to screen older patients (i.e.; ≥65 years) at risk of adverse health events. A prospective observational cohort design will be used for the study's two phases; phase 1- assessment and phase 2- assessment as well as recommendations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2017
CompletedFirst Submitted
Initial submission to the registry
August 9, 2018
CompletedFirst Posted
Study publicly available on registry
August 16, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2024
CompletedJuly 23, 2024
July 1, 2024
4 years
August 9, 2018
July 22, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Feasibility of using both tools in the ER
Percentage of participants with complete filed tools (older patients with tools filed / (older patients visiting the ER) x 100) will be calculated.
1 day
Prevalence of tools filed
Prevalence will be calculated for PRISMA-7, ER2 and pooled tools respectively.
1 day
Secondary Outcomes (3)
Feasibility of tools
1 day
Length of stay
1 day
Acute medical events
1 day
Interventions
To measure the effects of recommendations of ER2, the investigators will use ER users who will have an ER2 assessment without any recommendations as the referent group the older. This choice is possible because ER2 will be integrated into ER care in two steps: The first step will be limited to its assessment component in order to learn how to use the tool. The second step will be to follow the recommendations provided after the assessment. Participants will follow-up during their hospitalization via a review of their chart. They will be censored when they will be discharged from the JGH or when the duration of hospitalization will exceed 31 days.
Eligibility Criteria
They will be separated in four main groups: 1. Those without any PRISMA-7 and ER2. 2. Those with PRISMA-7 and without ER2. 3. Those with ER2 and without PRISMA-7. 4. Those with PRISMA-7 and ER2. Each group of participants with PRISMA-7 and ER2 will be divided in two subgroups: those with all items completed and a score, and those with incomplete tools.
You may qualify if:
- Age ≥ 65 years.
- Unplanned ER visits.
You may not qualify if:
- Death within the 24 hours of first visiting ER.
- Palliative care due to ER visit.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jewish General Hospital
Montreal, Quebec, H3T 1E2, Canada
Related Publications (1)
Beauchet O, Afilalo M, Allali G, Lubov J, Galery K, Launay CP. "Emergency Room Evaluation and Recommendations" and Incident Hospital Admissions in Older People with Major Neurocognitive Disorders Visiting Emergency Department: Results of an Experimental Study. Dement Geriatr Cogn Disord. 2022;51(3):291-296. doi: 10.1159/000524533. Epub 2022 May 12.
PMID: 35551122DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Olivier Beauchet
Jewish General Hospital - Lady Davis Institute
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Geriatrics
Study Record Dates
First Submitted
August 9, 2018
First Posted
August 16, 2018
Study Start
September 1, 2017
Primary Completion
September 1, 2021
Study Completion
July 1, 2024
Last Updated
July 23, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share